Yuki Nakano

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsOptical technologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2026
Discrepancies in Vancomycin Clearance Estimation Among Renal Function Models in Patients With Low Serum Creatinine Levels: A Pilot Study.

|May 13, 2026
Pharmacokinetic and pharmacogenomic profile of capecitabine and oxaliplatin in a patient with gastric cancer undergoing hemodialysis: a case report.

|Feb 07, 2026
Biphasic dysglycemia induced by pentamidine and detected by intermittently scanned continuous glucose monitoring: a case report of a possible drug-drug interaction with clopidogrel and literature review.

Yuki Nakano, Noriko Kuhara, Rintaro Sogawa

|Sep 22, 2025
Linezolid-related Optic Nerve Disorders: Insight From a Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System.

Yuki Nakano, Motoyasu Miyazaki, Arisa Fukuyama

|Jun 08, 2024
Association between roxadustat use and suppression of thyroid function: a systematic review and meta-analysis.

Yuki Nakano, Satoru Mitsuboshi, Kazuhiro Tada

Pageof 1

Frequent Collaborators

2 joint publications

Toshinori Hirai

1 joint publications

Motoyasu Miyazaki

1 joint publications

Nao Nishijo

1 joint publications

Yugo Uematsu